Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial

BACKGROUND: The use of rosuvastatin plus colchicine and emtricitabine/tenofovir in hospitalized patients with SARS-CoV-2 disease (COVID-19) has not been assessed. The objective of this study was to assess the effectiveness and safety of rosuvastatin plus colchicine, emtricitabine/tenofovir, and thei...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaitán-Duarte, H.G., Álvarez-Moreno, C., Rincón-Rodríguez, C.J., Yomayusa-González, N., Cortés, J.A., Villar, J.C., Bravo-Ojeda, J.S., García-Peña, A., Adarme-Jaimes, W., Rodríguez-Romero, V.A., Villate-Soto, S.L., Buitrago, G., Chacón-Sarmiento, J., Macias-Quintero, M., Vaca, C.P., Gómez-Restrepo, C., Rodríguez-Malagón, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686571/
https://www.ncbi.nlm.nih.gov/pubmed/34957385
http://dx.doi.org/10.1016/j.eclinm.2021.101242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686571/
https://www.ncbi.nlm.nih.gov/pubmed/34957385
http://dx.doi.org/10.1016/j.eclinm.2021.101242

Ejemplares similares